Document is current
Any future updates will be listed below
-
Authors
Landek-Salgado, M A
Faust, T E
Sawa, A
- License Information
-
More Information
Article History
Received: 26 July 2014
Revised: 24 June 2015
Accepted: 25 June 2015
First Online: 22 September 2015
Competing interests
: AS currently receives research funding from Johnson and Johnson, Astellas, Takeda, Tanabe-Mitsubishi, Dainippon-Sumitomo and Sucampo; has served as an advisory board and consultant for Amgen, Asubio, Eli Lilly, Pfizer, Sucampo, Taisho and Takeda, and collaborated with Afraxis, Astrazeneca and Sanofi-Aventis. However, none of these relationships affected the contents and statements of this review article.
